Back to Search Start Over

Effect of a diet based on Iranian traditional medicine on inflammatory markers and clinical outcomes in COVID-19 patients: A double-blind, randomized, controlled trial.

Authors :
Hajibeygi R
Mirghazanfari SM
Pahlavani N
Jalil AT
Alshahrani SH
Rizaev JA
Hadi S
Hadi V
Yekta NH
Source :
European journal of integrative medicine [Eur J Integr Med] 2022 Oct; Vol. 55, pp. 102179. Date of Electronic Publication: 2022 Aug 20.
Publication Year :
2022

Abstract

Introduction: SARS-CoV-2 causes severe acute respiratory syndrome prompting worldwide demand for new antiviral treatments and supportive care for organ failure caused by this life-threatening virus. This study aimed to help develop a new Traditional Persian Medicine (TPM) -based drug and assess its efficacy and safety in COVID-19 patients with major symptoms.<br />Methods: In February 2022, a randomized clinical trial was conducted among 160 patients with a confirmed diagnosis of COVID-19 admitted to Emam Reza (AJA) Hospital in Tehran, Iran. During their hospitalization, the intervention group received a treatment protocol approved by Iran's Ministry of Health and Medical Education (MOHME), consisting of an Iranian regimen, Ficus carica; Vitis vinifera, Safflower, Cicer arietinum, Descurainiasophia seeds, Ziziphus jujuba, chicken soup, barley soup, rose water, saffron, and cinnamon spices. All patients were compared in terms of demographics, clinical, and laboratory variables.<br />Results: One hundred and sixty COVID-19 patients were divided into two groups: intervention and control. In baseline characteristics, there was no significant difference between the intervention and control groups ( p >0.05). Using SPSS software version 22, statistical analysis revealed a significant difference in four symptoms: myalgia, weakness, headache, and cough ( p <0.05). During the 5-day treatment period, the control group had significantly lower C-reactive protein ( p <0.05).<br />Conclusion: While more research with a larger sample size is needed, the proposed combination appears to be effective in the treatment of symptoms as well as inflammatory biomarkers such as C-reactive protein in COVID-19 patients.Iranian registry of clinical trials (IRCT) IRCT20220227054140N1.<br />Competing Interests: The authors declare that they have no known competing financial interests or personal relationship that could have appeared to influence the work reported in this paper.<br /> (© 2022 Elsevier GmbH. All rights reserved.)

Details

Language :
English
ISSN :
1876-3820
Volume :
55
Database :
MEDLINE
Journal :
European journal of integrative medicine
Publication Type :
Academic Journal
Accession number :
36035633
Full Text :
https://doi.org/10.1016/j.eujim.2022.102179